| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Summer Road LLC serves as a 10% Owner at OCUL. Across recent SEC filings that breaks down to 34 buys and 0 sells. Those positions are worth an estimated $64.6M at current prices.
Historically, Summer Road LLC's trades have earned a below-average insider score of 47/100 across 24 rated trades. Over a 12-month horizon, 12.5% of those trades were profitable, with an average 12-month return of -25.9%.
The biggest single holding is OCUL (~$64.6M). Net of sales, the recent Form 4 record there shows accumulation of 4,786,613 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 40,510 | $6.61 | $267,796.39 | +0.7% | -23.6% | -56.5% | |
| Dec 8, 2021 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 60,900 | $6.18 | $376,603.00 | +1.1% | -22.7% | -59.2% | |
| Oct 16, 2020 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 437 | $10.48 | $4,579.76 | - | - | - | |
| May 19, 2020 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 363,636 | $5.50 | $1,999,998.00 | +6.9% | - | - | |
| Mar 24, 2020 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 109,100 | $4.71 | $514,198.43 | +2.1% | - | - | |
| Mar 19, 2020 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 385,838 | $4.62 | $1,783,423.80 | +8.1% | - | - | |
| Mar 17, 2020 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 955,062 | $4.55 | $4,346,089.81 | +25.1% | - | - |